• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宿主内和宿主间进化对病毒致癌性的影响。

Within- and between-host evolutionary effects on viral oncogenicity.

作者信息

Koizumi Yoshiki, Bonsall Michael B

机构信息

Department of Biology, University of Oxford, South Parks Road, Oxford OX1 3RB, United Kingdom.

AIDS Clinical Center, National Center for Global Health and Medicine, Japan Institute for Health Security, 1-21-1 Toyama, Shinjuku-ku, Tokyo 162-8655, Japan.

出版信息

Virus Evol. 2025 Jun 6;11(1):veaf043. doi: 10.1093/ve/veaf043. eCollection 2025.

DOI:10.1093/ve/veaf043
PMID:40606504
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12218219/
Abstract

Cancer-inducing viruses (oncogenic viruses) are linked to over 10% of cancer cases. Although the molecular details of viral oncogenesis are well-documented, the evolutionary mechanisms by which viruses have acquired oncogenic properties remain poorly understood. Here, we investigate the evolutionary conditions affecting viral oncogenicity across both within- and between-host scales using mathematical models of oncovirus-immune system interactions, conceptualized as an extended shared enemy-victim relationship. We begin by examining how oncogenic traits impact within-host viral dynamics, focusing on the transformation rate of infected cells into pre-cancerous states and the pre-cancerous cell proliferation rate. In various scenarios reflecting different within-host conditions, we then identify the transformation and proliferation rates that maximize within- and between-host viral fitness. We find that the transformation rate maximizing the viral load depends on the viral production rate, immunogenicity, and the immune-mediated elimination rate of pre-cancerous cells. We also identify conditions under which an intermediate proliferation rate minimizes within- and between-host viral fitness: in that scenario, a lower or higher proliferation rate leads to a higher viral load, providing a possible explanation for the diversity of oncogenic viruses. The analyses presented here provide insights into the evolutionary drivers affecting viral oncogenicity and highlight the complexity of oncogenic virus-immune system interactions.

摘要

致癌病毒(致癌性病毒)与超过10%的癌症病例相关。尽管病毒致癌作用的分子细节已有充分记录,但病毒获得致癌特性的进化机制仍知之甚少。在此,我们使用肿瘤病毒-免疫系统相互作用的数学模型,从宿主内和宿主间尺度研究影响病毒致癌性的进化条件,将其概念化为一种扩展的共同敌害-受害者关系。我们首先研究致癌特性如何影响宿主内病毒动态,重点关注感染细胞向癌前状态的转化率和癌前细胞增殖率。在反映不同宿主内条件的各种情况下,我们随后确定使宿主内和宿主间病毒适应性最大化的转化率和增殖率。我们发现,使病毒载量最大化的转化率取决于病毒产生率、免疫原性以及癌前细胞的免疫介导清除率。我们还确定了中间增殖率使宿主内和宿主间病毒适应性最小化的条件:在该情况下,较低或较高的增殖率会导致更高的病毒载量,这为致癌病毒的多样性提供了一种可能的解释。本文所呈现的分析为影响病毒致癌性的进化驱动因素提供了见解,并突出了致癌病毒-免疫系统相互作用的复杂性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cf0/12218219/cdd2917ba3d5/veaf043f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cf0/12218219/e4ed2f69e97b/veaf043f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cf0/12218219/1fcf86884d77/veaf043f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cf0/12218219/efaa20296e34/veaf043f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cf0/12218219/10ea47814d18/veaf043f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cf0/12218219/01cd014d5989/veaf043f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cf0/12218219/cdd2917ba3d5/veaf043f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cf0/12218219/e4ed2f69e97b/veaf043f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cf0/12218219/1fcf86884d77/veaf043f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cf0/12218219/efaa20296e34/veaf043f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cf0/12218219/10ea47814d18/veaf043f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cf0/12218219/01cd014d5989/veaf043f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cf0/12218219/cdd2917ba3d5/veaf043f6.jpg

相似文献

1
Within- and between-host evolutionary effects on viral oncogenicity.宿主内和宿主间进化对病毒致癌性的影响。
Virus Evol. 2025 Jun 6;11(1):veaf043. doi: 10.1093/ve/veaf043. eCollection 2025.
2
Modelling the effects of phylogeny and body size on within-host pathogen replication and immune response.建立模型以探究系统发育和体型对宿主内病原体复制和免疫反应的影响。
J R Soc Interface. 2017 Nov;14(136). doi: 10.1098/rsif.2017.0479.
3
Carbon dioxide detection for diagnosis of inadvertent respiratory tract placement of enterogastric tubes in children.用于诊断儿童肠胃管意外置入呼吸道的二氧化碳检测
Cochrane Database Syst Rev. 2025 Feb 19;2(2):CD011196. doi: 10.1002/14651858.CD011196.pub2.
4
A MicroRNA Screen Identifies the Wnt Signaling Pathway as a Regulator of the Interferon Response during Flavivirus Infection.一项微小RNA筛选确定Wnt信号通路是黄病毒感染期间干扰素反应的调节因子。
J Virol. 2017 Mar 29;91(8). doi: 10.1128/JVI.02388-16. Print 2017 Apr 15.
5
How to Implement Digital Clinical Consultations in UK Maternity Care: the ARM@DA Realist Review.如何在英国产科护理中实施数字临床会诊:ARM@DA实证主义综述
Health Soc Care Deliv Res. 2025 May 21:1-77. doi: 10.3310/WQFV7425.
6
Immunogenicity and seroefficacy of pneumococcal conjugate vaccines: a systematic review and network meta-analysis.肺炎球菌结合疫苗的免疫原性和血清效力:系统评价和网络荟萃分析。
Health Technol Assess. 2024 Jul;28(34):1-109. doi: 10.3310/YWHA3079.
7
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.社区居住的老年人跌倒预防干预措施:系统评价和荟萃分析的益处、危害以及患者的价值观和偏好。
Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3.
8
Ineffectual immunity in a resurrected mouse model of persistent viremia.持续性病毒血症复活小鼠模型中的无效免疫。
J Virol. 2025 Jun 17;99(6):e0024825. doi: 10.1128/jvi.00248-25. Epub 2025 May 8.
9
Does Augmenting Irradiated Autografts With Free Vascularized Fibula Graft in Patients With Bone Loss From a Malignant Tumor Achieve Union, Function, and Complication Rate Comparably to Patients Without Bone Loss and Augmentation When Reconstructing Intercalary Resections in the Lower Extremity?对于因恶性肿瘤导致骨缺损的患者,在重建下肢节段性切除时,采用带血管游离腓骨移植来增强照射后的自体骨移植,其骨愈合、功能及并发症发生率与无骨缺损且未进行增强的患者相比是否相当?
Clin Orthop Relat Res. 2025 Jun 26. doi: 10.1097/CORR.0000000000003599.
10
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.

本文引用的文献

1
Cancer risk in people living with HIV and solid organ transplant recipients: a systematic review and meta-analysis.HIV 感染者和实体器官移植受者的癌症风险:系统评价和荟萃分析。
Lancet Oncol. 2024 Jul;25(7):933-944. doi: 10.1016/S1470-2045(24)00189-X.
2
Mathematical methods for scaling from within-host to population-scale in infectious disease systems.从传染病系统的个体内尺度到群体尺度的数学方法。
Epidemics. 2023 Dec;45:100724. doi: 10.1016/j.epidem.2023.100724. Epub 2023 Oct 30.
3
Contact-number-driven virus evolution: A multi-level modeling framework for the evolution of acute or persistent RNA virus infection.
联系人数量驱动的病毒进化:急性或持续性 RNA 病毒感染进化的多层次建模框架。
PLoS Comput Biol. 2023 May 30;19(5):e1011173. doi: 10.1371/journal.pcbi.1011173. eCollection 2023 May.
4
Cross-scale dynamics and the evolutionary emergence of infectious diseases.跨尺度动力学与传染病的进化出现
Virus Evol. 2021 Apr 20;7(1):veaa105. doi: 10.1093/ve/veaa105. eCollection 2021 Jan.
5
Delineating the evolutionary dynamics of cancer from theory to reality.描绘癌症从理论到现实的进化动力学。
Nat Cancer. 2020 Jun;1(6):580-588. doi: 10.1038/s43018-020-0079-6. Epub 2020 Jun 22.
6
Viral and cellular oncogenes promote immune evasion.病毒癌基因和细胞癌基因促进免疫逃逸。
Oncogene. 2022 Feb;41(7):921-929. doi: 10.1038/s41388-021-02145-1. Epub 2022 Jan 13.
7
In vivo kinetics of SARS-CoV-2 infection and its relationship with a person's infectiousness.SARS-CoV-2 感染的体内动力学及其与个体传染性的关系。
Proc Natl Acad Sci U S A. 2021 Dec 7;118(49). doi: 10.1073/pnas.2111477118.
8
The evolutionary dynamics of viruses: virion release strategies, time delays and fitness minima.病毒的进化动力学:病毒粒子释放策略、时间延迟与适应度最小值
Virus Evol. 2021 Apr 27;7(1):veab039. doi: 10.1093/ve/veab039. eCollection 2021 Jan.
9
Mechanistic Modeling of SARS-CoV-2 and Other Infectious Diseases and the Effects of Therapeutics.SARS-CoV-2 和其他传染病的机制建模及治疗效果。
Clin Pharmacol Ther. 2021 Apr;109(4):829-840. doi: 10.1002/cpt.2160. Epub 2021 Mar 8.
10
A theoretical framework for transitioning from patient-level to population-scale epidemiological dynamics: influenza A as a case study.从患者层面到人群规模的流行病学动态转变的理论框架:以甲型流感为例。
J R Soc Interface. 2020 May;17(166):20200230. doi: 10.1098/rsif.2020.0230. Epub 2020 May 13.